Nanogen (Semper Idem)

A nanogen, also known as a evobiotic in British English, is any general type of semi-organic component or nanotech agent primarily used to treat bacterial and viral infections , and in some cases, help with general health issues relating to the human body. The majority of nanogens inhibit normal bacterial processes, similar to most antibiotics.

The field of nanomedicine was primarily focused on health and data collection, but as technology in the field progressed, researchers pondered for other uses for such technology. The transistor debate and the Great Panic slowed down process in this field significantly. Government institutions soon became the largest pioneer in this field, by 2035, the Rockefeller Initiative and the University of Stanford both achieved the first modern nanogen designs.

Nanogens are broadly classified into two major classifications, A-class and D-class. Most nanogens operate by binding to microorganisms in specific positions, to either infiltrate the organism or kill it immediately.

In order for nanogens to operate, a computer algorithm must first map out more than 100,000+ possible combinations for the nanogen to bind to any specific organism. Then, artificial proteins can be synthesised and combined to produce nanogens. Because of their delicate nature, many nanogens are tightly bound until ingested or injected.

In many countries, nanogens have become a simple alternative to drug-resistant bacteria. Due to their high manufacturing costs and delicate nature, nanogens are often only used to treat serious infections, and often cannot be used effectively to stop epidemics.

Nanogens are a prime example of synthetic biology, and there have been controversies surrounding its use and manufacture, as well as a general movement against it.

Production
Many nanogens are produced similarly to antibiotics - with genetically modified organisms that can mass-produce sufficient nanogens. However, this process requires up to a decade of research and genetic manipulation to create a suitable product, and the resulting product may not be completely effective.

Another much rarer method is with microtech synthesis, whereas protein molecules and amino acids are assembled with small nanotech components that assemble the nanogens. While this leads to a generally effective process, it results in much less production and still requires years of research.